arrow
D

Daniela Zob

Institute of Oncology
H指数:8
被引数:209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miRNA and Its Implications in the Treatment Resistance in Breast Cancer—Narrative Review of What Do We Know So Far

miRNA及其在乳腺癌治疗耐药性中的意义——关于我们目前所知内容的叙事性综述

2025-11-190
OAAI
Enhancing Prognosis in Advanced Ovarian Cancer: Primary Cytoreductive Surgery and Adjuvant Chemotherapy or Neoadjuvant Chemotherapy and Interval Cytoreduction-A Single-Center Retrospective Observational Study

提高晚期卵巢癌预后:初次肿瘤细胞减灭术与辅助化疗或新辅助化疗与间隔肿瘤细胞减灭术——一项单中心回顾性观察研究

CANCERS
IF4.4
2025-04-140
OA
Exploring the clinical utility of Oncotype DX in ER+/HER2-, N0 and N1 breast cancer patients: Insights from a Romanian cohort

探索Oncotype DX在ER+/HER2-, N0和N1乳腺癌患者中的临床应用价值:来自罗马尼亚队列的见解

BREAST
IF7.9
2025-02-010
OAAI
Treatment Strategies In Advanced Ovarian Cancer: Primary Cytoreductive Surgery And Adjuvant Chemotherapy Versus Neoadjuvant Chemotherapy And Interval Cytoreduction - A Single-Center Retrospective Observational Study From Romania

高级卵巢癌的治疗策略:初次肿瘤细胞减灭术和辅助化疗与术前新辅助化疗和间隔肿瘤细胞减灭术——一项来自罗马尼亚的单中心回顾性观察性研究

2025-02-010
PRE